Stocks and InvestingStocks and Investing
Tue, May 19, 2020
Mon, May 18, 2020
Fri, May 15, 2020
Thu, May 14, 2020

Mani Foroohar Reiterated (BBIO) at Buy with Decreased Target to $39 on, May 14th, 2020


Published on 2024-10-27 06:26:15 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $41 to $39 on, May 14th, 2020.

Mani has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mani


  • Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $50 on, Monday, April 13th, 2020
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020
  • Salim Syed of "Mizuho" Initiated at Strong Buy and Held Target at $51 on, Wednesday, February 19th, 2020